Head-to-Head

Halozyme Therapeutics, Inc. vs. Twist Bioscience Corporation Common Stock

HALO

Halozyme Therapeutics, Inc.

$93.09 +0.06%

VS TWST

Twist Bioscience Corporation Common Stock

$118.41 +5.72%

Halozyme Therapeutics, Inc. and Twist Bioscience Corporation Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

HALOTWST
Market Cap $10.61 billion $7.64 billion

HALO leads on 1 of 1 size & scale factors.

Risk & Sentiment

HALOTWST
Short Interest 9.75% 0.08%

TWST leads on 1 of 1 risk & sentiment factors.

Dig deeper: HALO overview, HALO financials, TWST overview, TWST financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.